Subscribe now

Health

Stem cells grown in labs for experimental therapies pose a cancer risk

Around one-fifth of the stem cells grown in laboratories for as-yet-unapproved medical treatments have cancer-causing mutations

By Clare Wilson

19 February 2024

Stem cells can be obtained from unneeded embryos made during in vitro fertilisation

nobeastsofierce Science / Alamy

A kind of stem cell transplant that has long been seen as one of the most promising new kinds of medical treatments could bring a greater risk of cancer than we previously thought. A study has found that more than a fifth of stem cells being grown in laboratories for regenerative medicine research harbour cancer-causing mutations.

The cells tested haven’t been put into people, but were being used in research to explore their medical use. The findings show that multiplying cells in a dish can cause the dangerous mutations…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop